Siciliano won the Science Center’s 2025 Commercialization Award in recognition of his outstanding contributions to the commercialization of innovative science and technology. ViTToria, which was co-founded by Marco Ruella, MD, Assistant Professor of Medicine in the Division of Hematology and Oncology at Penn Medicine, is focused on discovering and developing immunotherapies for difficult-to-treat diseases. Read more here.